# Contact TB-500 Meds: Editorial Inquiries and Corrections

> Contact TB-500 Meds about the editorial digest of TB-500 and thymosin beta-4 research — corrections, citation questions, and source suggestions. Not a clinic, not a vendor, no products sold.

Corrections, citation questions, and pointers to studies we missed. Editorial only.

## Reach the editors

This is an editorial contact channel for TB-500 Meds. Use it to flag a factual error, ask where a figure on the site comes from, or point us to a thymosin beta-4 or TB-500 study we should read. We take corrections seriously — if a number here does not match its cited source, we want to fix it.

What this channel is not: it is not a medical or clinical service, and we cannot answer personal health questions, recommend doses, or advise on use. We do not sell, supply, source, or price any substance, and we cannot help you obtain one. Questions of that kind belong with a licensed healthcare professional, not an editorial digest.

## Send a message

Use the form below for editorial inquiries and corrections. Tell us which page and which citation number your message concerns, and we will route it accordingly. We read every note about an error in the published record.

The most useful corrections are specific: the page, the sentence, the figure, and the source you think is right. "The stroke dose is wrong" is harder to act on than "the dose-response on /neuro-research should read 2, 12 and 18 mg/kg, per Morris 2014." Concrete pointers to studies we have not covered are welcome too — this digest grows by adding sourced findings, not by adding opinions.

## What we can and cannot help with

We can help with: corrections to cited figures, questions about a source, suggestions for studies to add, and clarifications about the fragment-versus-full-length distinction. We cannot help with: medical advice, dosing, sourcing, purchasing, or anything that treats this site as a vendor or a clinic. For the current regulatory picture, see [TB-500 legal status and FDA 503A category](/legal-status).

---

The TB-500 record drawn as a comic page — each repair figure, stroke dose and safety signal inked into its own panel and logged to its study, the fragment-versus-full-length caveat stamped on every page, with no clinic behind the gutters and nothing here dispensed or sold.